Free Trial

RxSight (RXST) SEC Filings & 10K Form

RxSight logo
$24.90 +0.05 (+0.20%)
Closing price 03/20/2025 04:00 PM Eastern
Extended Trading
$24.89 -0.01 (-0.04%)
As of 03/20/2025 05:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent RxSight SEC Filings

DateFilerForm TypeView
03/13/2025
3:46 PM
Fountain Tamara (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
7:03 PM
Kurtz Ronald M MD (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
7:04 PM
RxSight (Issuer)
Thunen Shelley B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
7:05 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
7:06 PM
RxSight (Issuer)
Weinberg Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
3:54 PM
RxSight (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/25/2025
3:15 PM
RxSight (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
5:04 PM
BANK OF AMERICA CORP /DE/ (Filed by)
RxSight (Subject)
Form SCHEDULE 13G
02/13/2025
12:20 PM
LORD, ABBETT & CO. LLC (Filed by)
RxSight (Subject)
Form SCHEDULE 13G/A
01/27/2025
3:40 PM
Maniar Shweta (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
2:56 PM
Maniar Shweta (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/17/2025
6:08 PM
Corley Jesse Anderson (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
5:01 AM
RxSight (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2024
5:38 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
12:29 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/26/2024
6:25 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
6:26 PM
Maniar Shweta (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/26/2024
1:45 PM
Maniar Shweta (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
3:15 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
8:50 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
3:18 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
6:42 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
6:14 PM
Corley Jesse Anderson (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
4:46 PM
RA CAPITAL MANAGEMENT, L.P. (Filed by)
RxSight (Subject)
Form SC 13G/A
11/12/2024
3:50 PM
RxSight (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/12/2024
8:40 AM
Artisan Partners Limited Partnership (Filed by)
RxSight (Subject)
Form SC 13G/A
11/08/2024
3:00 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
1:17 PM
BlackRock, Inc. (Filed by)
RxSight (Subject)
Form SC 13G/A
11/05/2024
3:05 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
3:17 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
12:52 PM
RxSight (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
4:22 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
3:28 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/28/2024
7:55 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:15 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/25/2024
3:15 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/22/2024
7:17 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
5:06 PM
BlackRock, Inc. (Filed by)
RxSight (Subject)
Form SC 13G/A
10/22/2024
3:16 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2024
4:23 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
3:23 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Elon Musk is helping print “new gold” (Ad)

MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”.

I reveal all of the details here.
10/16/2024
3:16 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/15/2024
3:23 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
7:23 AM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/11/2024
3:17 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/08/2024
5:00 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:19 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/04/2024
3:23 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/30/2024
7:05 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:14 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/26/2024
3:09 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/23/2024
5:48 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:41 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:15 PM
Goldshleger Ilya (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
4:57 PM
Kurtz Ronald M MD (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:19 PM
Goldshleger Ilya (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
7:15 PM
RxSight (Issuer)
Thunen Shelley B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
6:12 PM
Kurtz Ronald M MD (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:54 PM
RxSight (Subject)
Thunen Shelley B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2024
2:29 PM
RxSight (Subject)
Thunen Shelley B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
5:45 PM
Andrews Julie (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:17 PM
LINK WILLIAM J PHD (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:20 PM
Maniar Shweta (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:23 PM
PALMISANO ROBERT J (Reporting)
RxSight (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
3:11 PM
RxSight (Issuer)
Tammenoms Bakker Juliet (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:30 PM
RxSight (Filer)
Form SD
Specialized Disclosure Report  
05/09/2024
3:59 PM
RxSight (Filer)
Form 424B5
05/08/2024
3:41 PM
RxSight (Filer)
Form 424B5
05/03/2024
10:48 AM
Kurtz Ronald M MD (Reporting)
RxSight (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/02/2024
3:58 PM
RxSight (Issuer)
Thunen Shelley B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
3:33 PM
RxSight (Subject)
Thunen Shelley B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/25/2024
3:30 PM
RxSight (Filer)
Form DEF 14A
04/25/2024
3:31 PM
RxSight (Filer)
Form DEFA14A
04/25/2024
3:32 PM
RxSight (Filer)
Form ARS
04/01/2024
3:18 PM
RxSight (Subject)
Thunen Shelley B (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:RXST) was last updated on 3/21/2025 by MarketBeat.com Staff
From Our Partners